To date the only efficient treatment of celiac disease is a lifelong gluten-free diet (GFD), which involves relevant lifestyle changes. Numerous methods measure adherence to GFD, but none is completely reliable. The aim of the study was to compare three frequently used methods to measure adherence to GFD and study factors that influence adherence to GFD. Eighty-one celiac patients 15 years or older, on GFD were evaluated by dietitian interview, a Celiac Dietary Adherence Test (CDAT) and blood antitransglutaminase antibodies (tTG). Factors influencing adherence were assessed by an ad-hoc questionnaire following WHO criteria. Adherent and non-adherent patients were classified in the same category in 44.4% of cases (n=36), (non-adherent=35.8% and adherent= 8.6%). In general, methods identified better non-adherent than adherent individuals. Among the 5 realms defined by WHO, when tTG (positive/negative) defined adherence, logistic regression identified ten significant variables (information about disease, income, education, cost of gluten-free products, eating in restaurants, time on GFD, symptoms at diagnosis, number of symptoms at time of diagnosis, other chronic diseases present, allergy/food intolerance plus a chronic disease and CD). Using the interview as reference, two variables were significant (self-perception of knowledge of the GFD, and presence of gastrointestinal symptoms when gluten is consumed). Results illustrate the difficulties of measuring both adherence to GFD and the factors that influences it. Further studies should explore new markers able to measure the amount of gluten necessary to activate autoantibodies production and the time they take to stop their production once the patient stops gluten ingestion.

Corporación de Apoyo al celíaco Macul Chile

Laboratory of Gastroenterology Institute of Nutrition and Food Technology INTA University of Chile Macul Chile

Literatura

000      

00000naa a2200000 a 4500

001      

bmc20015209

003      

CZ-PrNML

005      

20221105215539.0

007      

ta

008      

200928s2020 xxu f 000 0|eng||

009      

AR

024    7_

$a 10.12691/ijcd-8-3-4 $2 doi

040    __

$a ABA008 $d ABA008 $e AACR2 $b cze

041    0_

$a eng

044    __

$a xxu

100    1_

$a Vespa, María Catalina $u Laboratory of Gastroenterology, Institute of Nutrition and Food Technology, INTA, University of Chile, Macul, Chile; Corporación de Apoyo al celíaco (COACEL), Macul, Chile

245    10

$a Difficulties assessing adherence to gluten-free diet in celiac patients / $c María Catalina Vespa, Amaya Oyarzún Arancibia, Jimena Ayala Cid, Magdalena Araya Quezada

504    __

$a Literatura

520    9_

$a To date the only efficient treatment of celiac disease is a lifelong gluten-free diet (GFD), which involves relevant lifestyle changes. Numerous methods measure adherence to GFD, but none is completely reliable. The aim of the study was to compare three frequently used methods to measure adherence to GFD and study factors that influence adherence to GFD. Eighty-one celiac patients 15 years or older, on GFD were evaluated by dietitian interview, a Celiac Dietary Adherence Test (CDAT) and blood antitransglutaminase antibodies (tTG). Factors influencing adherence were assessed by an ad-hoc questionnaire following WHO criteria. Adherent and non-adherent patients were classified in the same category in 44.4% of cases (n=36), (non-adherent=35.8% and adherent= 8.6%). In general, methods identified better non-adherent than adherent individuals. Among the 5 realms defined by WHO, when tTG (positive/negative) defined adherence, logistic regression identified ten significant variables (information about disease, income, education, cost of gluten-free products, eating in restaurants, time on GFD, symptoms at diagnosis, number of symptoms at time of diagnosis, other chronic diseases present, allergy/food intolerance plus a chronic disease and CD). Using the interview as reference, two variables were significant (self-perception of knowledge of the GFD, and presence of gastrointestinal symptoms when gluten is consumed). Results illustrate the difficulties of measuring both adherence to GFD and the factors that influences it. Further studies should explore new markers able to measure the amount of gluten necessary to activate autoantibodies production and the time they take to stop their production once the patient stops gluten ingestion.

650    _7

$a dospělí $7 D000328 $2 czmesh

650    _7

$a ženské pohlaví $7 D005260 $2 czmesh

650    _7

$a lidé $7 D006801 $2 czmesh

650    _7

$a mužské pohlaví $7 D008297 $2 czmesh

650    17

$a celiakie $x dietoterapie $x imunologie $7 D002446 $2 czmesh

650    17

$a bezlepková dieta $7 D055050 $2 czmesh

650    _7

$a adherence pacienta $x statistika a číselné údaje $7 D010349 $2 czmesh

650    _7

$a rozhovory jako téma $7 D007407 $2 czmesh

650    _7

$a protilátky $7 D000906 $2 czmesh

650    _7

$a transglutaminasy $x antagonisté a inhibitory $7 D011503 $2 czmesh

650    _7

$a průzkumy a dotazníky $7 D011795 $2 czmesh

650    _7

$a logistické modely $7 D016015 $2 czmesh

650    _7

$a statistika jako téma $7 D013223 $2 czmesh

651    _7

$a Chile $7 D002677 $2 czmesh

700    1_

$a Arancibia, Amaya Oyarzún $u Laboratory of Gastroenterology, Institute of Nutrition and Food Technology, INTA, University of Chile, Macul, Chile

700    1_

$a Cid, Jimena Ayala $u Corporación de Apoyo al celíaco (COACEL), Macul, Chile

700    1_

$a Quezada, Magdalena Araya $u Laboratory of Gastroenterology, Institute of Nutrition and Food Technology, INTA, University of Chile, Macul, Chile; Corporación de Apoyo al celíaco (COACEL), Macul, Chile

773    0_

$t International journal of celiac disease $x 2334-3427 $g Roč. 8, č. 3 (2020), s. 90-94 $w MED00186448

856    41

$u http://www.sciepub.com/journal/index.aspx?id=ijcd $y domovská stránka časopisu

910    __

$a ABA008 $b B 2748 $c 280 $y p $z 0

990    __

$a 20200927163017 $b ABA008

991    __

$a 20221105215529 $b ABA008

999    __

$a ok $b bmc $g 1567328 $s 1105370

BAS    __

$a 3

BMC    __

$a 2020 $b 8 $c 3 $d 90-94 $i 2334-3427 $m International journal of celiac disease $x MED00186448

LZP    __

$c NLK189 $d 20221105 $a NLK 2020-36/dk